1. Tumor Microenvironment‐Related Sonodynamic Therapy Mediates Tumor Therapy
   Xiaodong Wang et al, 2023, Advanced Therapeutics CrossRef
2. Unveiling the mechanistic link between extracellular amyloid fibrils, mechano-signaling and YAP activation in cancer
   Francesco Farris et al, 2024, Cell Death & Disease CrossRef
3. Is there a role for traditional and complementary medicines in managing chronic fatigue? a systematic review of randomized controlled trials
   Yuxiao Li et al, 2023, Frontiers in Pharmacology CrossRef
4. USP47 deficiency in mice modulates tumor infiltrating immune cells and enhances antitumor immune responses in prostate cancer
   Qian-Lan Wang et al, 2024, Cancer Immunology, Immunotherapy CrossRef
5. Advances in the Immunomodulatory Properties of Glycoantigens in Cancer
   Valeria da Costa et al, 2022, Cancers CrossRef
6. Targeted delivery of T-cell agonists for enhancing immunotherapy
   Ling Mao et al, 2023, Journal of Drug Delivery Science and Technology CrossRef
7. The Cross Talk between Cellular Senescence and Melanoma: From Molecular Pathogenesis to Target Therapies
   Jiahua Liu et al, 2023, Cancers CrossRef
8. Translation of the 27-gene immuno-oncology test (IO score) to predict outcomes in immune checkpoint inhibitor treated metastatic urothelial cancer patients
   Robert S. Seitz et al, 2022, Journal of Translational Medicine CrossRef
9. Recent Advances and Challenges in Cancer Immunotherapy
   Chelsea Peterson et al, 2022, Cancers CrossRef
10. PD-1/PD-L1 and DNA Damage Response in Cancer
    Mateusz Kciuk et al, 2023, Cells CrossRef
11. Identification of immune‐related hub genes and construction of an immune‐related gene prognostic index for low‐grade glioma
    Jing Zhou et al, 2023, Journal of Cellular and Molecular Medicine CrossRef
12. Advances in Rolling Circle Amplification (RCA)‐Based DNA‐Functional Materials for Cancer Diagnosis and Therapy
    Xun You et al, 2024, Advanced NanoBiomed Research CrossRef
13. Promises and challenges for targeting the immunological players in the tumor micro-environment – Critical determinants for NP-based therapy
    Suresh P．K． et al, 2023, OpenNano CrossRef
14. M1 macrophage predicted efficacy of neoadjuvant camrelizumab combined with chemotherapy vs chemotherapy alone for locally advanced ESCC: A pilot study
    Shu Wang et al, 2023, Frontiers in Oncology CrossRef
15. Biomineralized MnO2 Nanoplatforms Mediated Delivery of Immune Checkpoint Inhibitors with STING Pathway Activation to Potentiate Cancer Radio-Immunotherapy
    Zheng Deng et al, 2023, ACS Nano CrossRef
16. Immune characteristics of dedifferentiated retroperitoneal liposarcomas and the reliability of regional samples in evaluating their tumor immune microenvironments
    Changsheng Zhou et al, 2024, World Journal of Surgical Oncology CrossRef
17. EXABS-249-NQ-CT Next Questions: Cellular Therapy
    Nathan Denlinger et al, 2023, Clinical Lymphoma Myeloma and Leukemia CrossRef
18. Nanoparticles targeting the adenosine pathway for cancer immunotherapy
    Kehua Jiang et al, 2024, Journal of Materials Chemistry B CrossRef